Why Parkinson's is Much More than the 'Tremor of the Hand'
Parkinson's Disease
Alpha-Synuclein on Trial
Parkinson's Disease

Alpha-Synuclein on Trial

At the World Parkinson Congress in Phoenix, two leading neuroscientists staged a “courtroom battle” over one of medicine’s most consequential questions: what actually drives Parkinson’s disease?

Profiles

 Johan Ericson: Our Stem Cells may be 10 Times More Effective
Profiles

Johan Ericson: Our Stem Cells may be 10 Times More Effective

Most researchers are trying to slow the progression of Parkinson’s disease or alleviate its symptoms. Professor Johan Ericson is attempting something far more radical: Growing new dopamine-producing cells at an industrial scale, then implanting them into the brain. Thus restoring function in patients suffering from Parkinson's.

Anders M. Leines: After the Image Changed
Profiles

Anders M. Leines: After the Image Changed

For more than a decade, Anders M. Leines has documented Parkinson’s from the inside. First, he wanted to change how the disease was seen. Ten years later, he returned to the same people, and found a darker story about time and identity.

Parkinson's Disease

Aging

The Wrong Suspect in the Cell’s Burn Chamber
Aging

The Wrong Suspect in the Cell’s Burn Chamber

For decades, scientists blamed the Krebs cycle and fat-burning machinery for making mitochondria leak toxic peroxide. But under moderate beta-oxidation, the usual suspects are exonerated. The real mystery is not why the cell is burning fuel—it’s what else inside the mitochondrion is making the dangerous exhaust.